HPA019829

antibody from Atlas Antibodies

Targeting: AMPH

Provider product page for HPA019829

Western blot

Immunocytochemistry

Immunohistochemistry

Antibody data

Antibody Data
Antigen structure
References [3]
Comments [0]
Validations
Immunohistochemistry [1]

Submit

Product number: HPA019829 - Provider product page
Provider: Atlas Antibodies
Proper citation: Atlas Antibodies Cat#HPA019829, RRID:AB_1844802
Product name: Anti-AMPH
Antibody type: Polyclonal
Description: Polyclonal Antibody against Human AMPH, Gene description: amphiphysin, Validated applications: ICC, IHC, WB, Uniprot ID: P49418, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Reactivity: Human
Host: Rabbit
Conjugate: Unconjugated
Isotype: IgG
Vial size: 100 µl
Concentration: 0.4 mg/ml
Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Handling: The antibody solution should be gently mixed before use.

AMPH protein structure - HPA019829 shown in red.

Submitted references Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Bergström S, Remnestål J, Yousef J, Olofsson J, Markaki I, Carvalho S, Corvol J, Kultima K, Kilander L, Löwenmark M, Ingelsson M, Blennow K, Zetterberg H, Nellgård B, Brosseron F, Heneka M, Bosch B, Sanchez‐Valle R, Månberg A, Svenningsson P, Nilsson P
Annals of Clinical and Translational Neurology 2021;8(7):1456-1470

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Bergström S, Öijerstedt L, Remnestål J, Olofsson J, Ullgren A, Seelaar H, van Swieten J, Synofzik M, Sanchez-Valle R, Moreno F, Finger E, Masellis M, Tartaglia C, Vandenberghe R, Laforce R, Galimberti D, Borroni B, Butler C, Gerhard A, Ducharme S, Rohrer J, Månberg A, Graff C, Nilsson P, Jiskoot L, Rowe J, de Mendonça A, Tagliavini F, Santana I, Le Ber I, Levin J, Danek A, Otto M, Frisoni G, Ghidoni R, Sorbi S, Pasquier F, Jelic V, Andersson C, Afonso S, Almeida M, Anderl-Straub S, Antonell A, Archetti S, Arighi A, Balasa M, Barandiaran M, Bargalló N, Bartha R, Bender B, Benussi A, Benussi L, Bessi V, Binetti G, Black S, Bocchetta M, Borrego-Ecija S, Bras J, Bruffaerts R, Cañada M, Cantoni V, Caroppo P, Cash D, Castelo-Branco M, Convery R, Cope T, Di Fede G, Díez A, Duro D, Fenoglio C, Ferrari C, Ferreira C, Fox N, Freedman M, Fumagalli G, Gabilondo A, Gasparotti R, Gauthier S, Gazzina S, Giaccone G, Gorostidi A, Greaves C, Guerreiro R, Heller C, Hoegen T, Indakoetxea B, Jiskoot L, Karnath H, Keren R, Langheinrich T, Leitão M, Lladó A, Lombardi G, Loosli S, Maruta C, Mead S, Meeter L, Miltenberger G, van Minkelen R, Mitchell S, Moore K, Nacmias B, Nicholas J, Olives J, Ourselin S, Padovani A, Panman J, Papma J, Peakman G, Pievani M, Pijnenburg Y, Polito C, Premi E, Prioni S, Prix C, Rademakers R, Redaelli V, Rittman T, Rogaeva E, Rosa-Neto P, Rossi G, Rosser M, Santiago B, Scarpini E, Schönecker S, Semler E, Shafei R, Shoesmith C, Tábuas-Pereira M, Tainta M, Taipa R, Tang-Wai D, Thomas D, Thompson P, Thonberg H, Timberlake C, Tiraboschi P, Todd E, Van Damme P, Vandenbulcke M, Veldsman M, Verdelho A, Villanua J, Warren J, Wilke C, Woollacott I, Wlasich E, Zetterberg H, Zulaica M
Molecular Neurodegeneration 2021;16(1)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.

Bedri SK, Nilsson OB, Fink K, Månberg A, Hamsten C, Ayoglu B, Manouchehrinia A, Nilsson P, Olsson T, Hillert J, Grönlund H, Glaser A
PloS one 2019;14(5):e0217208